News & Perspective

Feb 13, 2017

Feb 13, 2017

News Scan for Feb 13, 2017

H7N9 in China
Ebola super-spreaders
Handshake stewardship
Cholera vaccine in pregnancy
WNV seroprevalence and immune status

Jan 06, 2017

Jan 06, 2017

News Scan for Jan 06, 2017

Zika birth defects
Ebola lung findings
AFM increase
Botulism and prison hooch
Chikungunya vaccine plan

Dec 27, 2016

Dec 27, 2016
Map of Africa

Ebola vaccine highly effective in final trial results

In addition, phase 2 trial of an adenovirus-based vaccine shows it to be safe and immunogenic though protection less than prolonged. 

Dec 01, 2016

Dec 01, 2016

News Scan for Dec 01, 2016

MERS in animals
H5N6 human case
Scientists address Trump
XDR-PA and aromatherapy
Ebola sequelae
Reaction to smallpox vaccine

Nov 18, 2016

Nov 18, 2016

News Scan for Nov 18, 2016

Saudi MERS cases
Ebola convalescent blood
US bioterror threat
Dutch H1N1v case
Malaria vaccine in Africa

Nov 15, 2016

Nov 15, 2016
Ebola treatment unit

Mild Ebola cases may mean outbreak larger than thought

About 7.5% of close contacts tested positive, while another study dissected convalescent plasma use.

Oct 28, 2016

Oct 28, 2016

News Scan for Oct 28, 2016

Deadly measles complication
Meningitis B vaccine impact
NIH Ebola funds

Oct 26, 2016

Oct 26, 2016

News Scan for Oct 26, 2016

Jack Woodall dies
Saudi MERS case
H7N2 in ostriches
Ebola outcome in kids
Stewardship and antibiotics
Chikungunya drop

Oct 12, 2016

Oct 12, 2016
ZMapp Ebola drug research

Trial offers mixed view of Ebola drug ZMapp

"I would view the results . . . in an optimistic light," said lead author Richard Davey after the drug showed more than 90% efficacy.

Sep 20, 2016

Sep 20, 2016

News Scan for Sep 20, 2016

MERS in Austria
Global flu update
Triclosan-containing sutures
Ebola strain comparison

Pages

Sort Results

 

Narrow results

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»